Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

J Exp Med. 1987 Oct 1;166(4):991-8. doi: 10.1084/jem.166.4.991.

Abstract

The immunoregulatory effects of transforming growth factor beta (TGF-beta) and recombinant murine tumor necrosis factor alpha (rMuTNF-alpha) on CTL generation and activity were examined. The results demonstrate that TGF-beta, in a dose-dependent manner, inhibited CTL generation but not CTL activity. The inhibitory effects were detected only when TGF-beta was added within the first 48 h of the MLC. Little activity was seen when it was added thereafter, including the addition of TGF-beta to the cytotoxicity assay. The production of TNF-alpha, which occurs during early phases of the MLC and which is inhibited in the presence of TGF-beta, appears to have an important regulatory role, as altering the levels of TNF-alpha in an MLC can significantly influence CTL development. The inhibitory effects of TGF-beta on the MLC can be significantly reversed by the addition of rMuTNF-alpha to the cultures. These results demonstrate that TGF-beta can inhibit MLC and subsequent CTL generation at early stages of the reaction, and such inhibition may involve the suppression of TNF-alpha production.

MeSH terms

  • Animals
  • Antibodies
  • Female
  • Kinetics
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Peptides / pharmacology*
  • Recombinant Proteins / pharmacology*
  • T-Lymphocytes, Cytotoxic / cytology*
  • T-Lymphocytes, Cytotoxic / drug effects
  • Transforming Growth Factors
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Antibodies
  • Peptides
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Transforming Growth Factors